Nanoparticle composite hydrogel nerve conduit and preparation method thereof
A composite hydrogel and nanoparticle technology, applied in pharmaceutical formulations, prostheses, drug delivery, etc., can solve the problems of fast degradation rate, poor mechanical properties, etc., to promote elongation, meet mechanical requirements, and good biocompatibility sexual effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] 1) Dissolve miRNA-29a in DEPC water at a concentration of 110 μg / ml, then add ZIF-8 suspension to ZIF-8 at a concentration of 1 mg / ml, with a mass ratio of miRNA-29a to ZIF-8 of 2:100. The mixture is then incubated on a shaker at 500 rpm / min for 30 min. Finally, the solution was centrifuged at 12,000 rpm for 10 min to collect the pellet to obtain miRNA-29a@ZIF-8 nanoparticles.
[0029] 2) Gelatin dissolved in a buffered aqueous solution of 2-ethionisulfonic acid at a concentration of 0.02g / mL, followed by 0.01g / ml of tyramine hydrochloride, fully dissolved at 50 °C, after the solution was cooled to room temperature, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinateimide (0.37g / 0.11 g) were added, stirring reaction for 12h, after dialysis under deionized water environment for 4 days, lyophilization was given to obtain sponge gelatin modified products, It is tyramine-modified gelatin.
[0030] 3) Weigh 4g of secondary degummed silk and fully di...
Embodiment 2
[0033] 1) Dissolve miRNA-29a in DEPC water at a concentration of 110 μg / ml, then add ZIF-8 suspension to ZIF-8 at a concentration of 3 mg / ml, with a mass ratio of miRNA-29a to ZIF-8 of 6:100. Subsequently incubate the mixture on a shaker at 500 rpm for 30 min. Finally, the solution was centrifuged at 12,000 rpm for 10 min to collect the pellet to obtain miRNA-29a@ZIF-8 nanoparticles.
[0034]2) Gelatin dissolved in a 50mM 2-equinethanesulfonic acid buffered aqueous solution at a concentration of 0.02g / mL, followed by 0.01g / mL of tyramine hydrochloride, fully dissolved at 50 °C, after the solution was cooled to room temperature, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinateimide (0.37g / 0.11 g) were added, stirring reaction for 12h, dialysis in deionized water environment for 4 days, lyophilization was given to obtain sponge gelatin modified products, It is tyramine-modified gelatin.
[0035] 3) Weigh 4g of secondary degummed silk and fully disso...
Embodiment 3
[0038] 1) Dissolve miRNA-29a in DEPC water at a concentration of 110 μg / ml, then add ZIF-8 suspension to ZIF-8 at a concentration of 1.5 mg / ml, with a mass ratio of miRNA-29a to ZIF-8 of 4:100. Subsequently incubate the mixture on a shaker at 500 rpm for 30 min. Finally, the solution was centrifuged at 12,000 rpm for 10 min to collect the pellet to obtain miRNA-29a@ZIF-8 nanoparticles. The stability of miRNA-29a@ZIF-8 is judged by the change of its electrophoretic bands with the incubation time in serum, such as Figure 2 as shown.
[0039]2) Gelatin dissolved in a buffered aqueous solution of 2-malineacesulfonic acid at a concentration of 0.02g / ml, followed by 0.01g / ml of tyramine hydrochloride, dissolved sufficiently at 50 °C, after the solution was cooled to room temperature, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide (0.37g / 0.11 g) were added, stirred reaction for 12h, after dialysis under deionized water environment for 4 days, lyophil...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com